List of works - Michael P Boyle

A multicenter study of the effect of solution temperature on nasal potential difference measurements

scientific article published in August 2003

A new era in the treatment of cystic fibrosis: correction of the underlying CFTR defect.

scientific article published on 30 January 2013

A phase I trial of intranasal Moli1901 for cystic fibrosis

scientific article

Adult cystic fibrosis

scientific article published on 01 October 2007

Advancing clinical development pathways for new CFTR modulators in cystic fibrosis

scientific article

Appropriate goal level for 25-hydroxyvitamin D in cystic fibrosis

scientific article published on 10 March 2011

Assessing disease disclosure in adults with cystic fibrosis: the Adult Data for Understanding Lifestyle and Transitions (ADULT) survey Disclosure of disease in adults with cystic fibrosis.

scientific article

Biodegradable polymer nanoparticles that rapidly penetrate the human mucus barrier.

scientific article

Chronic expanding hematoma of the lung

scientific article published in December 2013

Common Gene Therapy Viral Vectors Do Not Efficiently Penetrate Sputum from Cystic Fibrosis Patients ⬇️

scientific article published on May 27, 2011

Cystic fibrosis: year in review ⬇️

scientific article published on 01 November 2010

Digitoxin for Airway Inflammation in Cystic Fibrosis: Preliminary Assessment of Safety, Pharmacokinetics, and Dose Finding.

scientific article published on 22 December 2016

Distal intestinal obstruction syndrome after surgery in cystic fibrosis

scientific article published on 01 December 2003

Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation

scientific article

Effect of adeno-associated virus-specific immunoglobulin G in human amniotic fluid on gene transfer.

scientific article published on March 2003

Eradication strategy for persistent methicillin-resistant Staphylococcus aureus infection in individuals with cystic fibrosis--the PMEP trial: study protocol for a randomized controlled trial

scientific article

Evidence of CFTR function in cystic fibrosis after systemic administration of 4-phenylbutyrate

scientific article

Failure of high-dose ergocalciferol to correct vitamin D deficiency in adults with cystic fibrosis

scientific article published on 28 April 2005

Highly compacted DNA nanoparticles with low MW PEG coatings: in vitro, ex vivo and in vivo evaluation.

scientific article published on 31 August 2011

Highly compacted biodegradable DNA nanoparticles capable of overcoming the mucus barrier for inhaled lung gene therapy

scientific article

Improving transition from pediatric to adult cystic fibrosis care: lessons from a national survey of current practices

scientific article published on 01 May 2008

Incidence and risk factors for multiple antibiotic-resistant Pseudomonas aeruginosa in cystic fibrosis

scientific article published on 23 July 2007

Key findings of the US Cystic Fibrosis Foundation's clinical practice benchmarking project.

scientific article published on April 2014

Levofloxacin pharmacokinetics in adult cystic fibrosis

scientific article

Limitation of infarct expansion and ventricular remodeling by late reperfusion. Study of time course and mechanism in a rat model

scientific article published on 01 December 1993

Longitudinal association between medication adherence and lung health in people with cystic fibrosis.

scientific article

Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR.

scientific article published on 17 May 2015

Minocycline-induced pancreatitis in cystic fibrosis.

scientific article published on April 2001

Modifier genes in cystic fibrosis lung disease.

scientific article

N-acetylcysteine enhances cystic fibrosis sputum penetration and airway gene transfer by highly compacted DNA nanoparticles.

scientific article published on 9 August 2011

Nonclassic cystic fibrosis and CFTR-related diseases

scientific article published on November 2003

Outcomes of adults with cystic fibrosis infected with antibiotic-resistant Pseudomonas aeruginosa

scientific article

Patients with Mutations in Gsα Have Reduced Activation of a Downstream Target in Epithelial Tissues due to Haploinsufficiency

scientific article published on 24 July 2007

Persistent methicillin-resistant Staphylococcus aureus and rate of FEV1 decline in cystic fibrosis

scientific article published on 31 July 2008

Prevalence and risk factors for recovery of filamentous fungi in individuals with cystic fibrosis.

scientific article published on 31 December 2009

Rapid Transport of Muco-Inert Nanoparticles in Cystic Fibrosis Sputum Treated with N -Acetyl Cysteine ⬇️

scientific article published on February 1, 2011

Rationale and design of a randomized trial of home electronic symptom and lung function monitoring to detect cystic fibrosis pulmonary exacerbations: the early intervention in cystic fibrosis exacerbation (eICE) trial.

scientific article published on 19 September 2013

Recombinant soluble CR1 suppressed complement activation, inflammation, and necrosis associated with reperfusion of ischemic myocardium

scientific article published on 01 January 1990

Respiratory epithelial gene expression in patients with mild and severe cystic fibrosis lung disease.

scientific article published on 13 April 2006

Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation.

scientific article published on 08 August 2011

So many drugs, so little time: the future challenge of cystic fibrosis care.

scientific article published in January 2003

Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis

scientific article

Strategies for improving transition to adult cystic fibrosis care, based on patient and parent views

scientific article published on 01 December 2001

The Association Between Depression, Lung Function, and Health-Related Quality of Life Among Adults With Cystic Fibrosis

article

The evidence for long-term benefits of restoration of CFTR function continues to grow

scientific article published in October 2015

The penetration of fresh undiluted sputum expectorated by cystic fibrosis patients by non-adhesive polymer nanoparticles.

scientific article published on 26 January 2009

The spectrum of CFTR-related disease

scientific article published on 01 June 2001

Unique presentations and chronic complications in adult cystic fibrosis: do they teach us anything about CFTR? ⬇️

scientific article published on November 16, 2000

Update on key emerging challenges in cystic fibrosis

scientific article published on 10 January 2014

Update on maintaining bone health in cystic fibrosis.

scientific article published on November 2006

List of works by Michael P Boyle

A multicenter study of the effect of solution temperature on nasal potential difference measurements

A new era in the treatment of cystic fibrosis: correction of the underlying CFTR defect.

A phase I trial of intranasal Moli1901 for cystic fibrosis

Adult cystic fibrosis

Advancing clinical development pathways for new CFTR modulators in cystic fibrosis

Appropriate goal level for 25-hydroxyvitamin D in cystic fibrosis

Assessing disease disclosure in adults with cystic fibrosis: the Adult Data for Understanding Lifestyle and Transitions (ADULT) survey Disclosure of disease in adults with cystic fibrosis.

Biodegradable polymer nanoparticles that rapidly penetrate the human mucus barrier.

Chronic expanding hematoma of the lung

Common Gene Therapy Viral Vectors Do Not Efficiently Penetrate Sputum from Cystic Fibrosis Patients ⬇️

Cystic fibrosis: year in review ⬇️

Digitoxin for Airway Inflammation in Cystic Fibrosis: Preliminary Assessment of Safety, Pharmacokinetics, and Dose Finding.

Distal intestinal obstruction syndrome after surgery in cystic fibrosis

Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation

Effect of adeno-associated virus-specific immunoglobulin G in human amniotic fluid on gene transfer.

Eradication strategy for persistent methicillin-resistant Staphylococcus aureus infection in individuals with cystic fibrosis--the PMEP trial: study protocol for a randomized controlled trial

Evidence of CFTR function in cystic fibrosis after systemic administration of 4-phenylbutyrate

Failure of high-dose ergocalciferol to correct vitamin D deficiency in adults with cystic fibrosis

Highly compacted DNA nanoparticles with low MW PEG coatings: in vitro, ex vivo and in vivo evaluation.

Highly compacted biodegradable DNA nanoparticles capable of overcoming the mucus barrier for inhaled lung gene therapy

Improving transition from pediatric to adult cystic fibrosis care: lessons from a national survey of current practices

Incidence and risk factors for multiple antibiotic-resistant Pseudomonas aeruginosa in cystic fibrosis

Key findings of the US Cystic Fibrosis Foundation's clinical practice benchmarking project.

Levofloxacin pharmacokinetics in adult cystic fibrosis

Limitation of infarct expansion and ventricular remodeling by late reperfusion. Study of time course and mechanism in a rat model

Longitudinal association between medication adherence and lung health in people with cystic fibrosis.

Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR.

Minocycline-induced pancreatitis in cystic fibrosis.

Modifier genes in cystic fibrosis lung disease.

N-acetylcysteine enhances cystic fibrosis sputum penetration and airway gene transfer by highly compacted DNA nanoparticles.

Nonclassic cystic fibrosis and CFTR-related diseases

Outcomes of adults with cystic fibrosis infected with antibiotic-resistant Pseudomonas aeruginosa

Patients with Mutations in Gsα Have Reduced Activation of a Downstream Target in Epithelial Tissues due to Haploinsufficiency

Persistent methicillin-resistant Staphylococcus aureus and rate of FEV1 decline in cystic fibrosis

Prevalence and risk factors for recovery of filamentous fungi in individuals with cystic fibrosis.

Rapid Transport of Muco-Inert Nanoparticles in Cystic Fibrosis Sputum Treated with N -Acetyl Cysteine ⬇️

Rationale and design of a randomized trial of home electronic symptom and lung function monitoring to detect cystic fibrosis pulmonary exacerbations: the early intervention in cystic fibrosis exacerbation (eICE) trial.

Recombinant soluble CR1 suppressed complement activation, inflammation, and necrosis associated with reperfusion of ischemic myocardium

Respiratory epithelial gene expression in patients with mild and severe cystic fibrosis lung disease.

Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation.

So many drugs, so little time: the future challenge of cystic fibrosis care.

Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis

Strategies for improving transition to adult cystic fibrosis care, based on patient and parent views

The Association Between Depression, Lung Function, and Health-Related Quality of Life Among Adults With Cystic Fibrosis

The evidence for long-term benefits of restoration of CFTR function continues to grow

The penetration of fresh undiluted sputum expectorated by cystic fibrosis patients by non-adhesive polymer nanoparticles.

The spectrum of CFTR-related disease

Unique presentations and chronic complications in adult cystic fibrosis: do they teach us anything about CFTR? ⬇️

Update on key emerging challenges in cystic fibrosis

Update on maintaining bone health in cystic fibrosis.